BBVA USA Bancshares’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $9.12M | Sell |
251,786
-13,029
| -5% | -$463K | 0.43% | 58 |
|
|
2020
Q4 | $9.75M | Sell |
264,815
-37,783
| -12% | -$1.39M | 0.5% | 40 |
|
|
2020
Q3 | $10.4M | Sell |
302,598
-4,782
| -2% | -$168K | 0.59% | 36 |
|
|
2020
Q2 | $9.54M | Sell |
307,380
-18,088
| -6% | -$615K | 0.57% | 38 |
|
|
2020
Q1 | $10.1M | Buy |
325,468
+19,230
| +6% | +$655K | 0.72% | 27 |
|
|
2019
Q4 | $11.4M | Sell |
306,238
-9,943
| -3% | -$354K | 0.65% | 34 |
|
|
2019
Q3 | $10.8M | Sell |
316,181
-15,747
| -5% | -$573K | 0.69% | 34 |
|
|
2019
Q2 | $13.6M | Sell |
331,928
-9,736
| -3% | -$387K | 0.82% | 27 |
|
|
2019
Q1 | $13.8M | Sell |
341,664
-3,927
| -1% | -$157K | 0.87% | 24 |
|
|
2018
Q4 | $14.3M | Sell |
345,591
-10,307
| -3% | -$428K | 1.02% | 18 |
|
|
2018
Q3 | $14.9M | Buy |
355,898
+2,012
| +0.6% | +$77.5K | 0.88% | 23 |
|
|
2018
Q2 | $12.2M | Sell |
353,886
-10,062
| -3% | -$344K | 0.77% | 30 |
|
|
2018
Q1 | $12.3M | Sell |
363,948
-30,533
| -8% | -$1.05M | 0.79% | 27 |
|
|
2017
Q4 | $13.6M | Sell |
394,481
-12,251
| -3% | -$418K | 0.86% | 23 |
|
|
2017
Q3 | $13.8M | Sell |
406,732
-26,836
| -6% | -$863K | 0.9% | 22 |
|
|
2017
Q2 | $13.8M | Sell |
433,568
-6,012
| -1% | -$190K | 0.91% | 25 |
|
|
2017
Q1 | $14.3M | Buy |
439,580
+14,650
| +3% | +$462K | 0.96% | 21 |
|
|
2016
Q4 | $13.1M | Buy |
424,930
+32,384
| +8% | +$989K | 0.92% | 23 |
|
|
2016
Q3 | $12.6M | Buy |
392,546
+42,948
| +12% | +$1.44M | 0.91% | 23 |
|
|
2016
Q2 | $11.7M | Buy |
349,598
+77,542
| +29% | +$2.47M | 0.88% | 25 |
|
|
2016
Q1 | $7.65M | Buy |
272,056
+66,916
| +33% | +$1.91M | 0.58% | 42 |
|
|
2015
Q4 | $6.28M | Sell |
205,140
-4,078
| -2% | -$128K | 0.47% | 56 |
|
|
2015
Q3 | $6.24M | Sell |
209,218
-403,894
| -66% | -$13M | 0.49% | 56 |
|
|
2015
Q2 | $19.5M | Sell |
613,112
-28,886
| -4% | -$941K | 1.08% | 19 |
|
|
2015
Q1 | $21.2M | Sell |
641,998
-29,220
| -4% | -$929K | 0.95% | 20 |
|
|
2014
Q4 | $19.8M | Sell |
671,218
-76,230
| -10% | -$2.19M | 0.9% | 22 |
|
|
2014
Q3 | $21M | Buy |
747,448
+9,210
| +1% | +$258K | 0.93% | 21 |
|
|
2014
Q2 | $20.8M | Buy |
738,238
+11,531
| +2% | +$329K | 0.9% | 21 |
|
|
2014
Q1 | $22.1M | Sell |
726,707
-31,154
| -4% | -$929K | 1.01% | 17 |
|
|
2013
Q4 | $22M | Buy |
757,861
+1,089
| +0.1% | +$31.7K | 0.96% | 19 |
|
|
2013
Q3 | $20.6M | Buy |
756,772
+15,217
| +2% | +$414K | 0.99% | 17 |
|
|
2013
Q2 | $19.7M | Buy |
+741,555
| New | +$20.5M | 1% | 17 |
|
Other funds holding PFE
BBVA USA Bancshares's PFE Position: Q1 2021 in Review
BBVA USA Bancshares reduced its Pfizer (PFE) stake by 4.9% in Q1 2021, selling an estimated $463K and leaving 251,786 shares worth $9.12M. The position accounts for 0.43% of the portfolio, ranked #58.
BBVA USA Bancshares first reported a position in PFE in Q2 2013 and has held it in 32 quarters since. The position peaked at $22.1M in Q1 2014. 2,676 funds tracked by Wall St. Rank hold PFE as of Q1 2021.
- BBVA USA Bancshares held 251,786 shares of Pfizer worth $9.12M as of Q1 2021.
- BBVA USA Bancshares sold 13,029 Pfizer shares in Q1 2021, an estimated $463K.
- Pfizer made up 0.43% of BBVA USA Bancshares's portfolio in Q1 2021, its #58 holding.
- BBVA USA Bancshares first reported a position in Pfizer in Q2 2013 and has held it in 32 quarters since.
- BBVA USA Bancshares's Pfizer position peaked at $22.1M in Q1 2014.
- 2,676 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.